Obama to Send Congress Multitrillion-Dollar Budget Likely to Show Cutbacks

“In his Jan. 25 State of the Union address, the president proposed a five-year freeze on all annual appropriations for a savings of about $400 billion over a decade. It wouldn’t apply to defense, Medicare, Medicaid, Social Security and interest in the national debt. As a result, the freeze would apply to 18 percent of the budget, or $663 billion, in the current 2011 fiscal year, the CBO said in an economic outlook published Jan. 26. ” I don’t know about you, but I love when a freeze on a pithy 18% of the budget’s presumed automatic yearly increases is called “savings”.

Hedge Fund Fisticuffs: Does Anyone Really ‘Get It’?

““The current regulatory debate is a bit like discussing having better seat belts on planes. It’s hard to argue against, but when the plane crashes, it’s all a bit marginal …?the real focus of regulation should be on making the air traffic control system safe.” … What does that mean, you ask? Well, I have absolutely no idea. But, I suspect, neither does anyone else. Which is really the whole point, when you think about it. ”

Is housing hiding inflation in other sectors of the economy?

“In fact in the peak bubble years of 2004 through 2007 the CPI measure of housing only registered a 4 percent year-over-year change. We can measure this against the Case-Shiller Index that was measuring annual price changes across the United States above 15 percent. Can it be that the crashing housing market is underscoring the rising cost of goods in other sectors of the economy because of the heavy weighting of housing in the CPI? That is what we will explore today.”

Light therapy for early-stage laryngeal cancer

Light, or photodynamic, therapy can help preserve the voice and vocal cord function for patients with early stage laryngeal (voice box) cancer, according to a study from Henry Ford Hospital in Detroit.

“Photodynamic therapy is an effective treatment for early laryngeal squamous cell carcinomas, offering patients a less invasive option with fewer side effects than other therapies, while preserving the voice,” says study co-author Vanessa G. Schweitzer, FACS, M.D., a senior staff physician in the Department of Otolaryngology-Head & Neck Surgery at Henry Ford.

The study will be presented Jan. 29 at the Triological Society’s Combined Section Meeting in Scottsdale, Ariz.

Each year in the United States, more than 10,000 people are diagnosed with laryngeal cancer. Those who smoke and drink alcohol are at a greater risk, according to the National Cancer Institute. Laryngeal cancer is most commonly treated with radiation therapy alone or in combination with surgery or chemotherapy.

New Test Discovered to Better Predict Breast Cancer Outcomes

Researchers from McGill University’s Rosalind and Morris Goodman Cancer Research Centre (GCRC), the Research Institute of the McGill University Health Centre (RI MUHC), the Dana – Farber Cancer Institute and Harvard Medical School have discovered a gene signature that can accurately predict which breast cancer patients are at risk of relapse, thereby sparing those who are not from the burdens associated with unnecessary treatment.

For years, clinicians have been faced with the problem that breast cancer cannot be treated with a one-size-fits-all approach. Some cancers respond to specific treatments while others do not. Close to 50 per cent of breast cancer patients belong to a group – defined as “estrogen receptor positive/lymph node negative (ER+/LR-)”– that is at low risk of relapse. The majority of patients in this group may not require any treatment beyond the surgical removal of their tumour, while a small minority should receive additional treatment.

“The added information provided by our test would enable oncologists to identify those at very low risk of relapse, for whom the risk-benefit ratio might be in favour of withholding chemotherapy, and to identify patients in this low-risk group who would benefit from more aggressive treatments,” explains Dr. Alain Nepveu, GCRC and RI MUHC researcher and co-author of the study.

Yearly mammograms from age 40 save 71% more lives, study shows

A new study questions the controversial U.S. Preventative Service Task Force recommendations for breast cancer screening, with data that shows starting at a younger age and screening more frequently will result in more lives saved.

The study analyzed the same data looked at by the task force, which issued its guidelines on mammography screening in November 2009. The study authors compared the task force’s recommendations for screening every other year in women 50-74 to American Cancer Society guidelines of screening every year in women 40-84.

The study was conducted by R. Edward Hendrick, Ph.D., clinical professor of radiology at the University of Colorado School of Medicine, and Mark Helvie, M.D., director of breast imaging at the University of Michigan Comprehensive Cancer Center. It appears in the February issue of the American Journal of Roentgenology.

Breast implants may be linked to rare cancer: FDA

Women with silicone or saline breast implants may face a small increase in risk for a rare immune-system cancer near their implants, U.S. regulators said on Wednesday.

Officials need more data to tell if the implants caused the cancer and are asking doctors to report confirmed cases, the Food and Drug Administration said in a statement. Overall the agency still considers implants safe and said women without symptoms should not change their routine monitoring.

The cancer warning could hit sales of implants sold by Allergan Inc and Johnson & Johnson’s Mentor unit. Allergan shares closed down nearly 1.9 percent.